483 Wyeth Pharmaceutical Division of Wyeth Holdings Mar 2017

483 Wyeth Pharmaceutical Division of Wyeth Holdings Mar 2017

Maria Lopez- Barragan FDA, Diane Raccasi FDA, Wayne Seifert FDA$119.00 - Available Now

FDA investigators audited the Wyeth Pharmaceutical Division of Wyeth Holdings - Pearl River, NY, United States facility and issued inspectional observations (via FDA 483) on 17 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Mar 2017
  • Location: Pearl River, United States
  • FEI: 2410662
Add To Cart